When.com Web Search

Search results

1. Results From The WOW.Com Content Network

2. Management of migraine - Wikipedia

   en.wikipedia.org/wiki/Management_of_migraine

   Rescue treatment involves acute symptomatic control with medication. [4] Recommendations for rescue therapy of migraine include: (1) migraine-specific agents such as triptans, CGRP antagonists, or ditans for patients with severe headaches or for headaches that respond poorly to analgesics, (2) non-oral (typically nasal or injection) route of administration for patients with vomiting, (3) avoid ...

3. Eptinezumab - Wikipedia

   en.wikipedia.org/wiki/Eptinezumab

   The US Food and Drug Administration (FDA) approved eptinezumab based primarily on evidence from two clinical trials (Trial 1/NCT02559895 and Trial 2/NCT02974153) of 1741 participants with chronic or episodic migraine headaches. [10] Trials were conducted at 212 sites in United States, Georgia, Russia, Ukraine and the European Union. [10]

4. Triptan - Wikipedia

   en.wikipedia.org/wiki/Triptan

   The drugs of this class act as agonists for serotonin 5-HT 1B and 5-HT 1D receptors at blood vessels and nerve endings in the brain. The first clinically available triptan was sumatriptan, which has been marketed since 1991. Triptans have largely replaced ergotamines, an older class of medications used to relieve migraine and cluster headaches. [3]

5. Migraine-preventing drug significantly reduces rebound ... - AOL

   www.aol.com/migraine-preventing-drug...

   A drug used in the prevention of migraine may also help reduce so-called rebound headaches, according to a new review of data from a randomized, double-blind, placebo-controlled migraine trial.

6. Ditan - Wikipedia

   en.wikipedia.org/wiki/Ditan

   Ditans are a class of abortive medication for the treatment of migraines. [1] The first ditan, Eli Lilly's lasmiditan, was approved by the FDA in 2019. Ditans selectively bind to the 5-HT 1F receptor subtype.

7. FDA approves Pfizer's new nasal spray treatment for migraines

   www.aol.com/entertainment/fda-approves-pfizers...

   The U.S. Food and Drug Administration has approved Pfizer's newest drug on the migraine market, Zavzpret (zavegepant) -- the first and only migraine treatment of its kind to be offered in nasal spray.